A Day Up For Cara Therapeutics, Inc.
Tue, Dec 31, 2024 at 07:09 PM
Cara Therapeutics, Inc. (CARA:NASDAQ) rocketted at $6.12, a gain of 43.7%. On Tue, Dec 31, 2024, CARA:NASDAQ touched a New 2-Week High of $6.12. The stock got featured on our News Catalysts scanner on Fri, Dec 27, 2024 at 08:12 AM in the 'SPLIT' category. From Tue, Dec 17, 2024, the stock recorded 66.67% Up Days and 60.00% Green Days
About Cara Therapeutics, Inc. (CARA:NASDAQ)
Cara Therapeutics Inc is an emerging biotechnology company. It is focused on developing and commercializing new chemical entities designed to alleviate pain and pruritus by selectively targeting kappa opioid receptors.
Top 10 Gainers:
- Baird Medical Investment Holdings Ltd (BDMD:NASDAQ), 623.81%
- LMP Automotive Holdings, Inc. (LMPX:NASDAQ), 192.31%
- Smart for Life Inc. (SMFL:NASDAQ), 132.18%
- IT Tech Packaging, Inc. (ITP:NYSEMKT), 107.38%
- Aptorum Group Limited (APM:NASDAQ), 104.38%
- Twin Vee PowerCats Co. (VEEE:NASDAQ), 51.1%
- Abits Group Inc Ord (ABTS:NASDAQ), 48.15%
- Onconetix Inc Com (ONCO:NASDAQ), 44.16%
- NRX Pharmaceuticals Inc. (NRXP:NASDAQ), 43.79%
- Cara Therapeutics, Inc. (CARA:NASDAQ), 43.66%